ATI RN
ATI RN Pharmacology Proctored Exam 2023 Questions
Question 1 of 5
The client has osteomalacia, and the physician has ordered a treatment to restore calcium balance. What will the nurse plan to administer to the client?
Correct Answer: D
Rationale: Osteomalacia softens bones-vitamin D with calcium boosts absorption, correcting deficiency, per pathophysiology. Veggies and milk help but lack D's focus. Potassium is unrelated-D drives calcium use. This duo restores balance, per treatment.
Question 2 of 5
Which action is most important for the nurse to teach a patient who is taking tositumomab?
Correct Answer: C
Rationale: Tositumomab is a radioactive monoclonal antibody used in cancer treatment. Patients should be advised to use a separate bathroom and sit while urinating to minimize radiation exposure to others and themselves. This precaution is necessary because the drug is excreted in urine, which remains radioactive for a period after treatment. Avoiding alcohol or smoking is not specifically related to tositumomab therapy. Taking the drug on an empty stomach is not applicable, as it is administered intravenously.
Question 3 of 5
Nefopam:
Correct Answer: B
Rationale: Nefopam is contraindicated in epilepsy due to its potential for lowering the seizure threshold.
Question 4 of 5
The client has osteomalacia, and the physician has ordered a treatment to restore calcium balance. What will the nurse plan to administer to the client?
Correct Answer: D
Rationale: Osteomalacia softens bones-vitamin D with calcium boosts absorption, correcting deficiency, per pathophysiology. Veggies and milk help but lack D's focus. Potassium is unrelated-D drives calcium use. This duo restores balance, per treatment.
Question 5 of 5
A woman who wishes to become pregnant is concerned about the drugs she must take in order to treat a serious medical condition. The nurse reviewing the drug list would be most concerned about which kind of drug?
Correct Answer: A
Rationale: Long half-life drugs (e.g., diazepam) linger, risking fetal exposure post-conception, a pharmacokinetic worry for serious conditions. No active metabolites reduce risk. High protein-binding limits free drug, less concern. As-needed use minimizes exposure. Long half-life heightens teratogenic potential, critical in planning.